General Information of Drug (ID: DM797Z8)

Drug Name
NT0102
Indication
Disease Entry ICD 11 Status REF
Cardiovascular disease BA00-BE2Z Phase 3 [1]
Cross-matching ID
TTD ID
D0VW4J

References

1 ClinicalTrials.gov (NCT01835548) NT0102 in the Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD). U.S. National Institutes of Health.